SCHEMBL27496090

SCHEMBL27496090

COCCn1ncnc1CCl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 1/20 0.34
▸ MAOB P27338 2/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ LMNA P02545 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ ALOX15 P16050 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ TSHR P16473 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ MAOA P21397 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ GRM2 Q14416 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6340430 0.98 MAOB (0.33) MPOMAOBALDH1A1LMNATDP1
SCHEMBL6330210 0.82 MPO (0.34) MPOALDH1A1LMNATDP1ALOX15
SCHEMBL2648560 0.75 — —
SCHEMBL406366 0.69 HCAR3 (0.37) MPOMAOBALDH1A1LMNATDP1
Hydrochloric Acid SCHEMBL941062 0.69 — —
SCHEMBL25619105 0.68 MAPK1 (0.32) MPOALDH1A1MAPK1
SCHEMBL15703047 0.66 MEN1 (0.39) MPOMAOBALDH1A1LMNATDP1
SCHEMBL25864888 0.65 CNR2 (0.31) —
SCHEMBL15882053 0.64 MAOB (0.36) MPOMAOBALDH1A1LMNATDP1
SCHEMBL22363263 0.64 LRRK2 (0.41) MPOMAOBALDH1A1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1281588-C Novel intermediate for prepn. of pyrazolopyrimidinones PFIZER (US) 2006-10-25 — — CN disclosed
CN-1626516-A Novel intermediate for prepn. of pyrazolopyrimidinones PFIZER (US) 2005-06-15 — — CN disclosed
CN-1188415-C Pyrazolopyrimidinones inhibiting type 5 cyclic guanosine 3',5' -monophosphate phosphodiesterase (cG MP PDE5) for the treatment of sexual dysfunction PFIZER LTD (US) 2005-02-09 — — CN disclosed
CN-1253561-A Pyrazolopyrimidinones inhibiting type 5 cyclic guanosine 3',5' -monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction PFIZER LTD (US) 2000-05-17 — — CN disclosed
Send feedback